Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can learning to listen to your heart improve life with heart disease?

NCT ID NCT07697755

Symptom relief Sponsor: University of Glasgow Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 13, 2026 · Last updated Jul 14, 2026 · Updated 1 time

Summary

This study tests an 8-week online group program designed to help adults with congenital heart disease become more aware of internal body sensations like breathing, heart rate, and fatigue. The goal is to see if this approach is feasible and acceptable, and whether it can improve emotional well-being and quality of life. Thirty-two participants will be randomly assigned to start the program immediately or after a waiting period.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Interoceptive-Based Group Intervention (online skills program)
What this could lead to
If successful, this program could offer a new psychological support option for adults with congenital heart disease, helping them manage symptoms and improve quality of life.
What could go wrong
This is a small feasibility study with only 32 participants, so results may not apply to everyone. The program is new and its benefits are not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 32 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Dec 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Participants must be aged 18 years or older * Under the care of the Scottish Adult Congenital Cardiac Service (SACCS) at the Golden Jubilee University National Hospital (GJUNH) * Be able to understand and communicate in English * Provide informed consent * Access and use a device compatible with Microsoft Teams * Be able to commit to the duration of the group programme Exclusion Criteria: * Individuals with current suicidal ideation * Individuals with comorbid alcohol or substance use disorders * Individuals with a diagnosed learning disability * Individuals with a severe and enduring mental health condition (e.g., personality disorder or psychosis) * Individuals with hearing, visual and cognitive difficulties preventing safe online group participation * Individuals who are currently on a surgical or transplant waiting list * Individuals who are receiving intensive psychological treatment (e.g., trauma processing or crisis support)

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Congenital heart disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

congenital heart disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Congenital heart disease Interoception

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Golden Jubilee University National Hospital

    Glasgow, G81 4DY, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.